Innovative Approaches to Assessing Thyroid Disruption
Join US EPA Cell Biologist Chad Deisenroth, PhD, and LifeNet Health LifeSciences as they unveil a revolutionary human in vitro 3D thyroid microtissue model designed to evaluate thyroid hormone disruption.
Key Learnings:
- The need for a 3D human thyroid microtissue model to address current challenges with existing models.
- The importance of the model to screen chemicals for potential thyroid-disrupting effects.
- The methodology behind model standardization and validation.